代谢组学定义的肥胖与未来2型糖尿病及死亡风险
研究在瑞典和意大利三个队列共7663人中测量108种血浆代谢物,用岭回归预测BMI。代谢组可预测BMI(r²=0.48、0.26、0.19)。预测BMI高于实际BMI>5 kg/m²的瘦人,未来2型糖尿病风险高两倍,全因死亡风险增加80%,校正肥胖相关危险因素和生活方式后仍存在。
要点
- 代谢组可预测BMI,三个队列r²分别为0.48、0.26、0.19。
- 预测BMI高于实际>5 kg/m²的瘦人,未来2型糖尿病风险高两倍。
- 该组全因死亡风险增加80%,校正后仍存在。
核心结论
- 携带肥胖相关代谢组的瘦人比健康代谢组的瘦人未来2型糖尿病和全因死亡风险增加。
- 代谢组学可用于识别隐藏的高危个体以启动生活方式和药物干预。
研究设计与样本
- 在瑞典两个和意大利一个人群队列共7663人中测量血浆108种代谢物水平。
- 用岭回归以代谢物预测BMI,预测BMI高于或低于实际BMI>5 kg/m²者定义为离群值并进一步分析。
主要发现
- 代谢组在三个队列中均可预测BMI,r²分别为0.48、0.26和0.19。
- 高估组BMI与正确预测为正常体重者相似,腰围相似,随时间体重变化可能性未增加。
- 高估组未来2型糖尿病风险高两倍,全因死亡风险增加80%。
- 上述关联在校正肥胖相关危险因素和生活方式参数后仍存在。
临床怎么用
- 作者认为代谢组学可用于识别隐藏的高危个体以启动生活方式和药物干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obesity is a key risk factor for type 2 diabetes; however, up to 20% of patients are normal weight. Our aim was to identify metabolite patterns reproducibly predictive of BMI and subsequently to test whether lean individuals who carry an obese metabolome are at hidden high risk of obesity-related diseases, such as type 2 diabetes. RESEARCH DESIGN AND METHODS: Levels of 108 metabolites were measured in plasma samples of 7,663 individuals from two Swedish and one Italian population-based cohort. Ridge regression was used to predict BMI using the metabolites. Individuals with a predicted BMI either >5 kg/m2 higher (overestimated) or lower (underestimated) than their actual BMI were characterized as outliers and further investigated for obesity-related risk factors and future risk of type 2 diabetes and mortality. RESULTS: The metabolome could predict BMI in all cohorts (r2 = 0.48, 0.26, and 0.19). The overestimated group had a BMI similar to individuals correctly predicted as normal weight, had a similar waist circumference, were not more likely to change weight over time, but had a two times higher risk of future type 2 diabetes and an 80% increased risk of all-cause mortality. These associations remained after adjustments for obesity-related risk factors and lifestyle parameters. CONCLUSIONS: We found that lean individuals with an obesity-related metabolome have an increased risk for type 2 diabetes and all-cause mortality compared with lean individuals with a healthy metabolome. Metabolomics may be used to identify hidden high-risk individuals to initiate lifestyle and pharmacological interventions.
引用
- Ottosson F, Smith E, Ericson U, et al. Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality. Diabetes Care. 2022. PMID: 35287165. doi:10.2337/dc21-2402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。